4D Molecular Therapeutics, Inc.
FDMT· Nasdaq
4D Molecular Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -1.01%
- Market cap
- $755.88M
- 55.21M shares
- Filings
- 436
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $85,209,000 | reported | |
| FY 2024 | 2024-12-31 | $37,000 | reported | |
| FY 2023 | 2023-12-31 | $20,723,000 | reported | |
| FY 2022 | 2022-12-31 | $3,129,000 | reported | |
| FY 2021 | 2021-12-31 | $18,038,000 | reported | |
| FY 2020 | 2020-12-31 | $13,363,000 | reported | |
| FY 2019 | 2019-12-31 | $6,960,000 | reported |
4D Molecular Therapeutics, Inc. · CIK 1650648 · Engraved from SEC EDGAR
